Compare JSPR & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JSPR | AVD |
|---|---|---|
| Founded | 2018 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 28.4M |
| IPO Year | 2019 | 1995 |
| Metric | JSPR | AVD |
|---|---|---|
| Price | $14.35 | $0.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 321.1K | ★ 440.1K |
| Earning Date | 11-27-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.22 | ★ 61.11 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $515,114,000.00 |
| Revenue This Year | N/A | $7.74 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.32 | $0.81 |
| 52 Week High | $17.03 | $5.53 |
| Indicator | JSPR | AVD |
|---|---|---|
| Relative Strength Index (RSI) | 80.68 | 22.92 |
| Support Level | $0.64 | N/A |
| Resistance Level | $17.03 | $1.20 |
| Average True Range (ATR) | 1.05 | 0.10 |
| MACD | 1.15 | 0.01 |
| Stochastic Oscillator | 79.63 | 0.39 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.